VanEck Biotech ETF Rating $156.95 +1.44 (+0.93%) As of 10:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBH Aggregate RatingModerate Buy 2.65Holdings in BBH have an aggregate rating of Moderate Buy based on 476 analyst ratings issued in the past year covering 24 companies (100.0% of the portfolio).BBH Aggregate Price Target$155.51High Prediction$155.51Average Prediction$155.51Low Prediction$155.51Holdings in BBH have an aggregate price target of $155.51 and a range of $155.51 to $155.51 covering 24 companies (100.0% of the portfolio).BBH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 BBH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.81%AMGNAmgen$295.36+1.7%4.3174 of 5 stars2.35$307.82 4.2%2312.99%GILDGilead Sciences$112.40+0.6%4.843 of 5 stars2.78$110.55 -1.6%27Positive NewsInsider Trade10.58%VRTXVertex Pharmaceuticals$454.71+0.6%4.7266 of 5 stars2.54$511.62 12.5%28Positive News5.09%REGNRegeneron Pharmaceuticals$544.02+1.7%4.9403 of 5 stars2.80$813.57 49.5%25Analyst Downgrade4.93%ARGXargenex$554.38+2.2%4.3073 of 5 stars3.05$729.93 31.7%20Analyst Forecast4.86%ALNYAlnylam Pharmaceuticals$327.83+1.8%4.2888 of 5 stars2.79$340.00 3.7%24Positive NewsAnalyst Forecast4.60%NTRANatera$162.11+0.9%2.129 of 5 stars3.00$184.63 13.9%15Positive News4.54%IQVIQVIA$162.65+0.0%4.885 of 5 stars2.75$226.32 39.1%243.70%INSMInsmed$97.32-0.3%4.1193 of 5 stars3.00$106.80 9.7%17Positive News3.48%BIIBBiogen$132.27+1.7%4.9742 of 5 stars2.38$188.48 42.5%323.24%ICLRIcon$148.37-0.3%4.4916 of 5 stars2.60$213.08 43.6%152.97%BNTXBioNTech$107.20-0.3%2.465 of 5 stars2.83$137.86 28.6%182.97%ILMNIllumina$99.88+1.8%4.8688 of 5 stars2.47$127.39 27.5%19Positive News2.88%NBIXNeurocrine Biosciences$130.24+1.7%4.9388 of 5 stars2.86$162.00 24.4%22Positive News2.86%ONCBeOne Medicines$241.22-1.6%3.4839 of 5 stars3.00$320.67 32.9%6Gap Up2.35%MRNAModerna$29.60+3.2%4.3616 of 5 stars2.04$46.61 57.5%232.15%INCYIncyte$68.720.0%4.3669 of 5 stars2.22$74.53 8.5%181.83%TECHBio-Techne$52.28+0.4%4.9727 of 5 stars2.45$72.00 37.7%11Positive News1.74%QGENQiagen$47.79-0.4%3.7472 of 5 stars2.30$49.40 3.4%10Dividend Announcement1.62%CRLCharles River Laboratories International$154.25-0.1%4.3942 of 5 stars2.19$171.85 11.4%161.54%EXASExact Sciences$53.78-1.5%4.8821 of 5 stars2.95$70.40 30.9%22Analyst Revision1.51%BMRNBioMarin Pharmaceutical$57.10+1.6%4.9455 of 5 stars2.74$93.45 63.7%231.39%RGENRepligen$126.82+0.3%4.7966 of 5 stars2.69$172.83 36.3%13Positive NewsAnalyst Downgrade0.36%SRPTSarepta Therapeutics$18.02+1.8%4.731 of 5 stars2.44$60.88 237.8%25 This page (NASDAQ:BBH) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
